Towards a targeted, risk-based, antifungal strategy in neutropenic patients.
作者： H. Grant Prentice , ChriS. C. Kibbler , ArchiE. G. Prentice
DOI: 10.1046/J.1365-2141.2000.02014.X
关键词: Antifungal 、 Colony-stimulating factor 、 Internal medicine 、 Itraconazole Oral Solution 、 Immunology 、 Severity of illness 、 Neutropenia 、 Medicine 、 Amphotericin B 、 Remission Induction Therapy 、 Bacteremia
摘要:
sci-hub.se 参考文章(89)
H. Wandt, A. Trittin, W.V. Kern, S. Schwartz, V. Heinemann, G. Behre, E. Schilling, W. Hiddemann, W. Siegert, K. Lenz, M. Arning, D. Bosse, J. Beyer, O. Boenisch, W.D. Ludwig, Aerosolized Amphotericin B Inhalations as Prophylaxis of Invasive Aspergillus Infections During Prolonged Neutropenia: Results of a Prospective Randomized Multicenter Trial Blood. ,vol. 93, pp. 3654- 3661 ,(1999) , 10.1182/BLOOD.V93.11.3654
Tollemar J, Boström L, Nilsson B, Sundberg B, Ringdén O, Variables predicting deep fungal infections in bone marrow transplant recipients. Bone Marrow Transplantation. ,vol. 4, pp. 635- 641 ,(1989)
R. Saral, W. G. Merz, G. W. Santos, J. R. Wingard, S. U. Beals, Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplantation. ,vol. 2, pp. 175- 181 ,(1987)
N K Ramsay, Catherine Verfaillie, R Haake, D Weisdorf, P McGlave, M Hostetter, Candida infections in bone marrow transplant recipients Bone Marrow Transplantation. ,vol. 8, pp. 177- 184 ,(1991)
C. C Kibbler, R. Manuel, H G. Prentice, P. C Gotzsche, H. K. Johansen, Prophylactic and empirical antifungal treatment in cancer complicated by neutropenia. Combining different antifungal strategies in same systematic review is inappropriate. BMJ. ,vol. 315, pp. 488- 489 ,(1997) , 10.1136/BMJ.315.7106.488B
Tollemar J, Ljungman P, Sundberg B, Andersson S, Ringdén O, Tydén G, Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients. Bone Marrow Transplantation. ,vol. 12, pp. 577- 582 ,(1993)
E. Conneally, S. R. McCann, P. A. Daly, M. T. Cafferkey, C. T. Keane, Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplantation. ,vol. 5, pp. 403- 406 ,(1990)
M R O'Donnell, G M Schmidt, B R Tegtmeier, C Faucett, J L Fahey, J Ito, A Nademanee, J Niland, P Parker, E P Smith, Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. Journal of Clinical Oncology. ,vol. 12, pp. 827- 834 ,(1994) , 10.1200/JCO.1994.12.4.827
M. Boogaerts, F. Cavalli, H. Cortés-Funes, J.M. Gatell, A.M. Gianni, D. Khayat, Y. Levy, H. Link, Granulocyte growth factors: Achieving a consensus Annals of Oncology. ,vol. 6, pp. 237- 244 ,(1995) , 10.1093/OXFORDJOURNALS.ANNONC.A059152
Jeannie D. Chan, Pharmacokinetic drug interactions of vinca alkaloids: Summary of case reports Pharmacotherapy. ,vol. 18, pp. 1304- 1307 ,(1998) , 10.1002/J.1875-9114.1998.TB03152.X